EL7.AI
Stocks•9 July 2026•
1 min read

Small-Cap Stocks Rally Led by Julong Holding and Forte Biosciences

Key Facts

1Julong Holding shares surged 317.97% to $12.79 with trading volume exceeding 75 million shares despite no clear catalyst.
2Forte Biosciences posted strong gains following positive Phase 1b clinical data for its FB102 drug candidate.
3Virax Biolabs shares rose approximately 102% following an agreement involving the immediate exercise of warrants.

Amid a shift in retail sentiment toward growth assets, several small-cap stocks experienced explosive price action on July 9, 2026. Julong Holding shares surged 317.97% to reach $12.79, with trading volume exceeding 75 million shares despite no clear corporate catalyst. Meanwhile, Forte Biosciences posted significant gains following positive Phase 1b clinical data for its FB102 drug candidate, and Virax Biolabs rose approximately 102% after announcing an agreement for the immediate exercise of warrants.

This intense activity reflects a renewed appetite for risk within the small-cap and biotech sectors, which often react sharply to clinical milestones and financing updates. Compared to broader sector trends, the parabolic move in Julong Holding lacks fundamental backing, suggesting that technical speculation played a primary role in the rally, per market data. Such volatility is characteristic of low-float stocks during periods where investors seek high-alpha opportunities outside of mega-cap names.

On the macro front, broader market sentiment may be influenced by upcoming global catalysts, including the OPEC meeting scheduled for July 2026, which could impact overall liquidity and investor positioning in high-risk equity segments.